Drp1-mediated mitochondrial abnormalities link to synaptic injury in diabetes model

Diabetes

Volumn 64, Issue 5, 2015, Pages 1728-1742

  Huang, Shengbin ^a,b   Wang, Yongfu ^a   Gan, Xueqi ^a,b   Fang, Du ^a   Zhong, Changjia ^a   Wu, Long ^a   Hu, Gang ^a   Sosunov, Alexander A ^c   Mckhann, Guy M ^c   Yu, Haiyang ^b   Yan, Shirley ShiDu ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b SICHUAN UNIVERSITY   (China)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DYNAMIN; DYNAMIN RELATED PROTEIN 1; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; DNM1L PROTEIN, MOUSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DB/DB MOUSE; DIABETIC PATIENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN CELL; INJURY; LONG TERM POTENTIATION; MALE; MITOCHONDRIAL ABNORMALITY; MITOCHONDRION; MORPHOLOGY; MOUSE; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC INJURY; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL PLASTICITY; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINE; DYNAMINS; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, INBRED NOD; MITOCHONDRIA; NEURONAL PLASTICITY; NEURONS;

EID: 84940700273     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0758     Document Type: Article

References (66)

1. Schmidt RE, Parvin CA, Green KG. Synaptic ultrastructural alterations anticipate the development of neuroaxonal dystrophy in sympathetic ganglia of aged and diabetic mice. J Neuropathol Exp Neurol 2008;67:1166-1186.
2. Tay SS, Wong WC. Ultrastructural changes in the gracile nucleus of alloxaninduced diabetic rats. Acta Anat (Basel) 1990;139:367-373.
3. Greenwood CE, Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging 2005;26(Suppl. 1):42-45.
4. Desrocher M, Rovet J. Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 2004;10:36-52.
5. Biessels GJ, Kamal A, Ramakers GM, et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996;45: 1259-1266.
6. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Effects of insulin treatment. Brain Res 1998;800:125-135.
7. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of longterm potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 2002;113:607-615.
8. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008;11:309-317.
9. Zorzano A, Liesa M, Palacín M. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol 2009; 41:1846-1854.
10. Yoon Y, Galloway CA, Jhun BS, Yu T. Mitochondrial dynamics in diabetes. Antioxid Redox Signal 2011;14:439-457.
11. Stranahan AM, Arumugam TV, Lee K, Mattson MP. Mineralocorticoid receptor activation restores medial perforant path LTP in diabetic rats. Synapse 2010;64:528-532.
12. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 2005;26(Suppl. 1):26-30.
13. Yaffe K, Lindquist K, Schwartz AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 2011;77:1351-1356.
14. Yu T, Sheu SS, Robotham JL, Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res 2008;79:341-351.
15. Edwards JL, Quattrini A, Lentz SI, et al. Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia 2010;53:160-169.
16. Abbas T, Faivre E, Hölscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res 2009;205:265-271.
17. Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH. Diabetes mellitus concomitantly facilitates the induction of long- Term depression and inhibits that of long- Term potentiation in hippocampus. Eur J Neurosci 2005;22: 169-178.
18. Martín ED, Sánchez-Perez A, Trejo JL, et al. IRS-2 deficiency impairs NMDA receptor-dependent long- Term potentiation. Cereb Cortex 2012;22:1717-1727.
19. Nisticò R, Cavallucci V, Piccinin S, et al. Insulin receptor b-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromolecular Med 2012;14:262-269.
20. Shonesy BC, Thiruchelvam K, Parameshwaran K, et al. Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiol Aging 2012;33:430.e5-430.e18.
21. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010;26: 507-519.
22. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: A meta- Analysis. Diabetes Care 2005;28:726-735.
23. Kageyama Y, Zhang Z, Sesaki H. Mitochondrial division: molecular machinery and physiological functions. Curr Opin Cell Biol 2011;23:427-434.
24. Palmer CS, Osellame LD, Stojanovski D, Ryan MT. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 2011;23:1534-1545.
25. Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P. Dynaminrelated protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Brain Res Rev 2011;67:103-118.
26. Molina AJ, Wikstrom JD, Stiles L, et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 2009;58:2303-2315.
27. Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A 2006;103:2653-2658.
28. Bach D, Pich S, Soriano FX, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 2003;278:17190-17197.
29. Widlansky ME, Wang J, Shenouda SM, et al. Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl Res 2010;156:15-25.
30. Makino A, Scott BT, Dillmann WH. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 2010;53:1783-1794.
31. Vincent AM, Edwards JL, McLean LL, et al. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol 2010;120:477-489.
32. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005;307:384-387.
33. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51:2944-2950.
34. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491-495.
35. Du H, Guo L, Fang F, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008;14:1097-1105.
36. Wang Y, Wu L, Fang D, et al. Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease. J Alzheimers Dis 2015;43: 451-463.
37. Gan X, Huang S, Wu L, et al. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochim Biophys Acta 2013;1842:220-231.
38. Lustbader JW, Cirilli M, Lin C, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004;304:448-452.
39. Tieu K, Perier C, Caspersen C, et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 2003;112:892-901.
40. Xu H, Wu ZY, Fang F, et al. Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells. FASEB J 2010;24:1583-1592.
41. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of realtime quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999;270:41-49.
42. Jheng HF, Tsai PJ, Guo SM, et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 2012;32:309-319.
43. Gawlowski T, Suarez J, Scott B, et al. Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-b-N- Acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem 2012;287:30024-30034.
44. Shenouda SM, Widlansky ME, Chen K, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 2011;124: 444-453.
45. Men X, Wang H, Li M, et al. Dynamin-related protein 1 mediates high glucose induced pancreatic beta cell apoptosis. Int J Biochem Cell Biol 2009;41:879-890.
46. Kashatus DF, Lim KH, Brady DC, Pershing NL, Cox AD, Counter CM. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat Cell Biol 2011;13:1108-1115.
47. Cassidy-Stone A, Chipuk JE, Ingerman E, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 2008;14:193-204.
48. Wang Y, Feng W, Xue W, et al. Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling. Diabetes 2009;58:1391-1402.
49. Shuai H, Zhang J, Zhang J, et al. Role of stereotaxically injected IgG from db/db mice in the phosphorylation of the microtubule- Associated protein tau in hippocampus. Brain Res 2012;1486:14-26.
50. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-789.
51. Chen CH, Hwang SL, Howng SL, Chou CK, Hong YR. Three rat brain alternative splicing dynamin-like protein variants: interaction with the glycogen synthase kinase 3beta and action as a substrate. Biochem Biophys Res Commun 2000;268:893-898.
52. Hong YR, Chen CH, Cheng DS, Howng SL, Chow CC. Human dynamin-like protein interacts with the glycogen synthase kinase 3beta. Biochem Biophys Res Commun 1998;249:697-703.
53. Chou CH, Lin CC, Yang MC, et al. GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress. PLoS ONE 2012;7:e49112.
54. Martinez A, Alonso M, Castro A, Pérez C, Moreno FJ. First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J Med Chem 2002;45:1292-1299.
55. Kimura R, Ma LY, Wu C, et al. Acute exposure to the mitochondrial complex I toxin rotenone impairs synaptic long- Term potentiation in rat hippocampal slices. CNS Neurosci Ther 2012;18:641-646.
56. Kim HY, Lee KY, Lu Y, et al. Mitochondrial Ca(2+) uptake is essential for synaptic plasticity in pain. J Neurosci 2011;31:12982-12991.
57. Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008;60:748-766.
58. Levy M, Faas GC, Saggau P, Craigen WJ, Sweatt JD. Mitochondrial regulation of synaptic plasticity in the hippocampus. J Biol Chem 2003;278:17727-17734.
59. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125:1241-1252.
60. Chan DC. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 2006;22:79-99.
61. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMPdependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 2007;8:939-944.
62. Chang CR, Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 2007;282:21583-21587.
63. Han XJ, Lu YF, Li SA, et al. CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol 2008;182:573-585.
64. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 2007;282:11521-11529.
65. Yu T, Jhun BS, Yoon Y. High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen- Activated protein kinasemediated activation of mitochondrial fission. Antioxid Redox Signal 2011;14:425-437.
66. So EC, Hsing CH, Liang CH, Wu SN. The actions of mdivi-1, an inhibitor of mitochondrial fission, on rapidly activating delayed-rectifier K? current and membrane potential in HL-1 murine atrial cardiomyocytes. Eur J Pharmacol 2012;683:1-9.